Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	DCHS2 CLSTN3 NOTCH2NLA NBPF26 NOTCH2NLC ITPR3 FBN1 LTBP4 CACNA1B FBLN5 DSC3 DSG1 PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 THBS2 SLIT1 MACF1 DSG4 PCDHGA8 CRB2	1.19e-05	749	223	23	GO:0005509
GeneOntologyMolecularFunction	transmembrane receptor protein kinase activity	PTK7 LTBP4 HJV AMHR2 NTRK1 MST1R IGF2R	4.65e-05	85	223	7	GO:0019199
GeneOntologyMolecularFunction	extracellular matrix structural constituent	LAMA1 SSPOP MFAP4 FBN1 LTBP4 COL6A2 FBLN5 COL6A6 EMILIN1 THBS2	5.21e-05	188	223	10	GO:0005201
GeneOntologyMolecularFunction	extracellular matrix constituent conferring elasticity	FBN1 FBLN5 EMILIN1	2.81e-04	12	223	3	GO:0030023
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	DCHS2 CLSTN3 PTK7 IGSF9 DSC3 DSG1 PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 DSG4 IGSF9B PCDHGA8	1.07e-08	187	215	14	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	DCHS2 CLSTN3 PTK7 IGSF9 DSC3 DSG1 PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 DSG4 IGSF9B PCDHGA8 CRB2	1.10e-06	313	215	15	GO:0098742
GeneOntologyBiologicalProcess	elastic fiber assembly	MFAP4 LTBP4 FBLN5 EMILIN1	3.58e-06	11	215	4	GO:0048251
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	TRIO LAMA1 PTCH1 PTK7 UBE3A IGSF9 STRC STRCP1 ISLR2 ANK3 B4GAT1 KALRN NTRK1 OBSL1 GRIP1 KLF7 SLIT1 MACF1 ANKRD24 PAX2 PRKCQ	3.90e-05	748	215	21	GO:0048667
GeneOntologyBiologicalProcess	axon guidance	TRIO LAMA1 PTCH1 PTK7 IGSF9 ANK3 B4GAT1 KALRN NTRK1 KLF7 SLIT1 PRKCQ	4.76e-05	285	215	12	GO:0007411
GeneOntologyBiologicalProcess	neuron projection guidance	TRIO LAMA1 PTCH1 PTK7 IGSF9 ANK3 B4GAT1 KALRN NTRK1 KLF7 SLIT1 PRKCQ	4.92e-05	286	215	12	GO:0097485
GeneOntologyBiologicalProcess	regulation of cell cycle process	ERCC3 CEP295NL PIDD1 ATRIP TELO2 RECQL4 TIMELESS EME2 PLK1 ANAPC7 TBX1 USP47 KLF11 OBSL1 XRCC3 CTDSP2 KIF20A CDK5RAP2 ZFYVE26 TNKS PRKCQ TP53	7.74e-05	845	215	22	GO:0010564
GeneOntologyBiologicalProcess	cell cycle process	NES ERCC3 CEP295NL PIDD1 FANCA ATRIP TELO2 INSC RECQL4 TIMELESS PLEC EME2 PLK1 ANAPC7 TBX1 USP47 KLF11 ANK3 OBSL1 XRCC3 SYDE1 CTDSP2 KIF20A RGS14 MISP UHRF1 CDK5RAP2 ZFYVE26 TNKS PRKCQ TP53	9.64e-05	1441	215	31	GO:0022402
GeneOntologyBiologicalProcess	regulation of cell cycle phase transition	ERCC3 PIDD1 ATRIP TELO2 TIMELESS EME2 PLK1 ANAPC7 TBX1 USP47 KLF11 XRCC3 CTDSP2 CDK5RAP2 PRKCQ TP53	1.09e-04	516	215	16	GO:1901987
GeneOntologyBiologicalProcess	negative regulation of cell cycle process	PIDD1 ATRIP TELO2 RECQL4 TIMELESS EME2 PLK1 USP47 XRCC3 CTDSP2 CDK5RAP2 TNKS TP53	1.16e-04	362	215	13	GO:0010948
GeneOntologyBiologicalProcess	mitotic cell cycle	NES ERCC3 PIDD1 PTCH1 INSC EME2 PLK1 ANAPC7 USP47 KLF11 SRA1 ANK3 OBSL1 XRCC3 CTDSP2 KIF20A RGS14 MISP UHRF1 CDK5RAP2 ZFYVE26 TNKS PRKCQ TP53	1.57e-04	1014	215	24	GO:0000278
GeneOntologyBiologicalProcess	cell projection morphogenesis	NES CLSTN3 TRIO LAMA1 PTCH1 PTK7 CLU UBE3A IGSF9 ISLR2 ANK3 B4GAT1 KALRN NTRK1 OBSL1 GRIP1 KLF7 SLIT1 MACF1 PAX2 PRKCQ	1.57e-04	826	215	21	GO:0048858
GeneOntologyBiologicalProcess	double-strand break repair	ATRIP RECQL4 TIMELESS EME2 PLK1 RNF169 EP400 XRCC3 RNF126 UHRF1 ZFYVE26 TP53	1.60e-04	324	215	12	GO:0006302
GeneOntologyBiologicalProcess	double-strand break repair via homologous recombination	RECQL4 TIMELESS PLK1 RNF169 EP400 XRCC3 RNF126 UHRF1 ZFYVE26	1.64e-04	188	215	9	GO:0000724
GeneOntologyBiologicalProcess	recombinational repair	RECQL4 TIMELESS PLK1 RNF169 EP400 XRCC3 RNF126 UHRF1 ZFYVE26	2.07e-04	194	215	9	GO:0000725
Domain	CA	DCHS2 CLSTN3 FREM2 DSC3 DSG1 PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 DSG4 PCDHGA8	1.01e-08	115	218	12	SM00112
Domain	Cadherin	DCHS2 CLSTN3 FREM2 DSC3 DSG1 PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 DSG4 PCDHGA8	1.36e-08	118	218	12	IPR002126
Domain	CADHERIN_1	DCHS2 CLSTN3 DSC3 DSG1 PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 DSG4 PCDHGA8	8.73e-08	113	218	11	PS00232
Domain	Cadherin	DCHS2 CLSTN3 DSC3 DSG1 PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 DSG4 PCDHGA8	8.73e-08	113	218	11	PF00028
Domain	CADHERIN_2	DCHS2 CLSTN3 DSC3 DSG1 PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 DSG4 PCDHGA8	9.56e-08	114	218	11	PS50268
Domain	-	DCHS2 CLSTN3 DSC3 DSG1 PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 DSG4 PCDHGA8	9.56e-08	114	218	11	2.60.40.60
Domain	Cadherin-like	DCHS2 CLSTN3 DSC3 DSG1 PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 DSG4 PCDHGA8	1.14e-07	116	218	11	IPR015919
Domain	Cadherin_CS	DCHS2 DSC3 DSG1 PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 DSG4 PCDHGA8	5.95e-07	109	218	10	IPR020894
Domain	Spectrin_repeat	TRIO SPTBN5 PLEC KALRN MACF1	1.96e-05	29	218	5	IPR002017
Domain	-	EPPK1 PLEC MACF1	3.06e-05	6	218	3	3.90.1290.10
Domain	SPEC	TRIO SPTBN5 PLEC KALRN MACF1	3.22e-05	32	218	5	SM00150
Domain	Spectrin/alpha-actinin	TRIO SPTBN5 PLEC KALRN MACF1	3.22e-05	32	218	5	IPR018159
Domain	EGF_1	LAMA1 NOTCH2NLA NOTCH2NLC SSPOP ITGB7 FBN1 LTBP4 FBLN5 ZAN THBS2 SLIT1 CRB2	4.78e-05	255	218	12	PS00022
Domain	Desmosomal_cadherin	DSC3 DSG1 DSG4	5.30e-05	7	218	3	IPR009122
Domain	Plectin	EPPK1 PLEC MACF1	5.30e-05	7	218	3	PF00681
Domain	Plectin_repeat	EPPK1 PLEC MACF1	5.30e-05	7	218	3	IPR001101
Domain	PLEC	EPPK1 PLEC MACF1	5.30e-05	7	218	3	SM00250
Domain	Cadherin_tail	PCDHGA9 PCDHGA6 PCDHGA5 PCDHA13 PCDHGA8	6.65e-05	37	218	5	PF15974
Domain	Cadherin_CBD	PCDHGA9 PCDHGA6 PCDHGA5 PCDHA13 PCDHGA8	6.65e-05	37	218	5	IPR031904
Domain	EGF_2	LAMA1 NOTCH2NLA NOTCH2NLC SSPOP ITGB7 FBN1 LTBP4 FBLN5 ZAN THBS2 SLIT1 CRB2	6.92e-05	265	218	12	PS01186
Domain	EGF_CA	NOTCH2NLA NOTCH2NLC FBN1 LTBP4 FBLN5 THBS2 SLIT1 CRB2	9.33e-05	122	218	8	SM00179
Domain	EGF-like_Ca-bd_dom	NOTCH2NLA NOTCH2NLC FBN1 LTBP4 FBLN5 THBS2 SLIT1 CRB2	1.05e-04	124	218	8	IPR001881
Domain	Cadherin_2	PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 PCDHGA8	1.10e-04	65	218	6	PF08266
Domain	Cadherin_N	PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 PCDHGA8	1.10e-04	65	218	6	IPR013164
Domain	Cadherin_C	PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHGA8	1.24e-04	42	218	5	IPR032455
Domain	Cadherin_C_2	PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHGA8	1.24e-04	42	218	5	PF16492
Domain	Spectrin	TRIO SPTBN5 KALRN MACF1	1.34e-04	23	218	4	PF00435
Domain	EGF_Ca-bd_CS	NOTCH2NLA NOTCH2NLC FBN1 LTBP4 FBLN5 SLIT1 CRB2	1.41e-04	97	218	7	IPR018097
Domain	EGF_CA	NOTCH2NLA NOTCH2NLC FBN1 LTBP4 FBLN5 SLIT1 CRB2	1.61e-04	99	218	7	PS01187
Domain	EGF-type_Asp/Asn_hydroxyl_site	NOTCH2NLA NOTCH2NLC FBN1 LTBP4 FBLN5 SLIT1 CRB2	2.46e-04	106	218	7	IPR000152
Domain	EGF-like_CS	LAMA1 NOTCH2NLA NOTCH2NLC ITGB7 FBN1 LTBP4 FBLN5 ZAN THBS2 SLIT1 CRB2	2.59e-04	261	218	11	IPR013032
Domain	EGF	LAMA1 NOTCH2NLA NOTCH2NLC FBN1 LTBP4 FBLN5 ZAN THBS2 SLIT1 CRB2	4.56e-04	235	218	10	SM00181
Domain	EGF_3	NOTCH2NLA NOTCH2NLC SSPOP FBN1 LTBP4 FBLN5 ZAN THBS2 SLIT1 CRB2	4.56e-04	235	218	10	PS50026
Domain	EGF_CA	NOTCH2NLA NOTCH2NLC FBN1 LTBP4 FBLN5 THBS2	5.10e-04	86	218	6	PF07645
Domain	EGF-like_dom	LAMA1 NOTCH2NLA NOTCH2NLC FBN1 LTBP4 FBLN5 ZAN THBS2 SLIT1 CRB2	7.14e-04	249	218	10	IPR000742
Domain	Desmoglein	DSG1 DSG4	8.01e-04	4	218	2	IPR009123
Domain	ASX_HYDROXYL	NOTCH2NLA NOTCH2NLC FBN1 LTBP4 FBLN5 CRB2	1.13e-03	100	218	6	PS00010
Pathway	REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES	MFAP4 FBN1 LTBP4 FBLN5 EMILIN1	2.39e-05	32	155	5	MM14854
Pathway	REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES	MFAP4 FBN1 LTBP4 FBLN5 EMILIN1	4.94e-05	37	155	5	M27134
Pathway	REACTOME_FANCONI_ANEMIA_PATHWAY	RPS27A FANCA FANCE ATRIP EME2	6.41e-05	39	155	5	MM15318
Pathway	REACTOME_ELASTIC_FIBRE_FORMATION	MFAP4 FBN1 LTBP4 FBLN5 EMILIN1	6.41e-05	39	155	5	MM14601
Pathway	REACTOME_FANCONI_ANEMIA_PATHWAY	RPS27A FANCA FANCE ATRIP EME2	6.41e-05	39	155	5	M14990
Pathway	REACTOME_ELASTIC_FIBRE_FORMATION	MFAP4 FBN1 LTBP4 FBLN5 EMILIN1	1.16e-04	44	155	5	M26969
Pathway	PID_FANCONI_PATHWAY	SSPOP FANCA FANCE ATRIP XRCC3	1.59e-04	47	155	5	M1
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SETD1A RAPGEF6 EPPK1 TRIO PIEZO1 PFAS PTCH1 PLEKHH3 ITPR3 FANCA KMT2C PI4KA NFKB2 PLA2G6 MICAL3 PLEC CHPF LTBP4 GAREM1 EP400 KALRN HIP1R LRRK1 PHC2 CTDSP2 MST1R IGF2R EPOP HELZ2 ZFYVE26 PAX2	1.37e-11	1105	230	31	35748872
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	ZSWIM8 NOTCH2NLA CCDC88B TASOR2 FBN1 CLU UBE3A IGSF9 KAZN FHL2 LTBP4 VPS18 FBLN5 TUT4 KLC4 PHC2 GRIP1 SRRT SLIT1 ANKRD24 TP53	2.03e-10	560	230	21	21653829
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SETD1A RAPGEF6 EPPK1 PTCH1 TASOR2 NBPF19 ZNF469 PLEC BSN NBPF14 GAREM1 ANK3 EP400 NBPF20 NBPF9 TNKS IGSF9B TP53	7.47e-10	430	230	18	35044719
Pubmed	A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution.	NBPF19 NBPF14 NBPF8 NBPF20 NBPF9 NBPF10	3.91e-09	21	230	6	16079250
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	ZSWIM8 CLSTN3 RAPGEF6 MANBA ZNF185 NBPF26 PFAS RTN2 MFAP4 PLK1 SPOCD1 LTBP4 TUT4 CPD IPO4 KLC4 NPEPL1 CTDSP2 RNPEP MZF1 FIBCD1 UHRF1 DCXR TMCC1	1.47e-08	925	230	24	28986522
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SMG1 SETD1A KDM5C PIEZO1 ERMP1 NACAD KMT2C TELO2 IGSF9 BSN ISLR2 EP400 HIP1R LRRK1 NPEPL1 CDK5RAP2 KAT6B USP6NL	1.87e-08	529	230	18	14621295
Pubmed	Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: a two-stage Spanish case-control study.	ERCC3 FANCA FANCE ATRIP PLK1 SRA1 GRIP1 TP53	1.44e-07	89	230	8	18950845
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	MFAP4 FBN1 CLU LTBP4 COL6A2 FBLN5 EMILIN1 THBS2 RNPEP	6.10e-07	146	230	9	27068509
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	ZSWIM8 NOTCH2NLA SSPOP UBE3A KAZN FHL2 LTBP4 KLF11 FBLN5 KALRN KLC4 ATXN1L PHC2 SLIT1 KAT6B PBXIP1 TP53	7.42e-07	608	230	17	16713569
Pubmed	TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination.	MANBA CLU OS9 CHPF CHST7 DSC3 DSG1 MST1R IGF2R	1.61e-06	164	230	9	32409323
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ZSWIM8 DCHS2 CLSTN3 TRIO RPS27A FBN1 GRHPR CLU UBE3A DDX18 PLEC CHPF USP47 ANK3 B4GAT1 KALRN OBSL1 TARS3 MACF1 SPRED1 TNKS ANKRD24 ZNF565 SNRNP200 PBXIP1	1.62e-06	1285	230	25	35914814
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SMG1 RAPGEF6 GON4L PFAS PTK7 FANCA FREM2 CLU RECQL4 MICAL3 TIMELESS COL6A2 OBSL1 SYDE1 SRRT RHPN2 PBXIP1	1.83e-06	650	230	17	38777146
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	NES ZSWIM8 EPPK1 PFAS TASOR2 ITPR3 DDX18 PLEC USP47 NVL IPO4 IGF2R RNPEP HELZ2 MACF1 SNRNP200 TP53	1.95e-06	653	230	17	22586326
Pubmed	PLK1-dependent activation of LRRK1 regulates spindle orientation by phosphorylating CDK5RAP2.	PLK1 LRRK1 CDK5RAP2	2.83e-06	5	230	3	26192437
Pubmed	Proteotyping of knockout mouse strains reveals sex- and strain-specific signatures in blood plasma.	PIPOX MFAP4 PLK1 SRA1 MMACHC	2.88e-06	34	230	5	34050187
Pubmed	Breakdown of the reciprocal stabilization of QBRICK/Frem1, Fras1, and Frem2 at the basement membrane provokes Fraser syndrome-like defects.	LAMA1 FREM2 COL6A2 GRIP1	3.19e-06	16	230	4	16880404
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	MFAP4 FBN1 LTBP4 COL6A2 FBLN5 COL6A6 EMILIN1 THBS2	3.49e-06	135	230	8	28675934
Pubmed	Proteomics characterization of extracellular space components in the human aorta.	MFAP4 FBN1 CLU LTBP4 COL6A2 FBLN5 EMILIN1	5.12e-06	101	230	7	20551380
Pubmed	Latent transforming growth factor beta-binding proteins and fibulins compete for fibrillin-1 and exhibit exquisite specificities in binding sites.	FBN1 LTBP4 FBLN5	5.63e-06	6	230	3	19349279
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	SETD1A EPPK1 GLTP ERMP1 RPS27A ITPR3 KMT2C DDX18 PLEC HIP1R IPO4 NXN SRRT CYSTM1 MACF1 SNRNP200 DCXR	6.02e-06	711	230	17	33022573
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 PCDHGA8	6.09e-06	68	230	6	11230163
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	LAMA1 MFAP4 FBN1 CLU C2 LTBP4 COL6A2 FBLN5 EMILIN1 THBS2	6.74e-06	248	230	10	24006456
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 PCDHGA8	8.50e-06	72	230	6	10380929
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	NES ERCC3 RPS27A ITPR3 PI4KA DDX18 PLD2 PLEC NVL SRRT MISP UHRF1 MACF1 SNRNP200 USP6NL TP53	9.59e-06	660	230	16	32780723
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 PCDHGA8	9.97e-06	74	230	6	10817752
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	PIDD1 ITPR3 KMT2C PI4KA CACNA1B IPO4 RGS12 SLIT1 MACF1 RNF41 HTR3B	1.12e-05	322	230	11	26514267
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	SETD1A NES ERCC3 ZNF185 PFAS GRHPR UBE3A PI4KA DDX18 NFKB2 RECQL4 PLEC FHL2 PLK1 DSC3 EP400 DSG1 HIP1R CASP8 IPO4 KIF20A SRRT MACF1 SNRNP200	1.24e-05	1353	230	24	29467282
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 PCDHGA8	1.26e-05	77	230	6	10835267
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 PCDHGA8	1.57e-05	80	230	6	10716726
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	LAMA1 FREM2 MFAP4 FBN1 LTBP4 COL6A2 FBLN5 EMILIN1	1.66e-05	167	230	8	22159717
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	CLSTN3 MANBA PIEZO1 LAMA1 NBPF26 ERMP1 PTK7 FANCA FBN1 ATRIP OAF CLU TMEM106C TIMELESS CHPF FBLN5 B4GAT1 CPD MST1R IGF2R UHRF1 PBXIP1	1.79e-05	1201	230	22	35696571
Pubmed	Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.	ERCC3 FANCA FANCE AMHR2 SRA1 XRCC3 IGF2R TP53	1.89e-05	170	230	8	19064572
Pubmed	Systematic screening for skin, hair, and nail abnormalities in a large-scale knockout mouse program.	NES TSPAN18 ERMP1 ATRIP HJV NXN VSIG8 HTR3B	1.97e-05	171	230	8	28700664
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	PIEZO1 PFAS RPS27A PTK7 ITPR3 TELO2 CLU PI4KA DDX18 OS9 DNAJC24 ANK3 DSC3 OBSL1 NVL CPD IPO4 IGF2R MACF1 CDK5RAP2 SNRNP200 DCXR PBXIP1 TMCC1 USP6NL	1.99e-05	1487	230	25	33957083
Pubmed	Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.	LAMA1 FBN1 CLU COL6A2 EMILIN1	2.01e-05	50	230	5	23658023
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TRIO NOTCH2NLA SSPOP TASOR2 PTK7 KMT2C TXNL4B OS9 IGSF9 PLA2G6 MICAL3 TUT4 ANK3 FRMPD1 CPD NXN PPARGC1B KLF7 MACF1 ZFHX3 ANKRD24 IGSF9B KAT6B CYP4F11 TMCC1	2.03e-05	1489	230	25	28611215
Pubmed	Interactome Analysis of Human Phospholipase D and Phosphatidic Acid-Associated Protein Network.	ZSWIM8 MANBA PFAS ERMP1 PTK7 TELO2 OS9 PLD2 CHPF B4GAT1	2.05e-05	282	230	10	35007762
Pubmed	Expression of Developmentally Important Axon Guidance Cues in the Adult Optic Chiasm.	NES SLIT1 PAX2	2.33e-05	9	230	3	31731293
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	LAMA1 SSPOP FBN1 LTBP4 COL6A2 FBLN5 COL6A6 EMILIN1	2.33e-05	175	230	8	28071719
Pubmed	A protein interaction landscape of breast cancer.	EPPK1 TRIO ZNF185 ITPR3 PI4KA OS9 ANK3 HIP1R CASP8 RIOX1 XRCC3 IGF2R MACF1 PBXIP1 TP53	2.42e-05	634	230	15	34591612
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	RAPGEF6 TRIO PTK7 PI4KA MICAL3 ANK3 DSC3 CPD GRIP1 IGF2R MACF1 USP6NL	2.71e-05	421	230	12	36976175
Pubmed	Mice lacking the giant protocadherin mFAT1 exhibit renal slit junction abnormalities and a partially penetrant cyclopia and anophthalmia phenotype.	DSC3 DSG1 DSG4	3.31e-05	10	230	3	12724416
Pubmed	Tel2 regulates the stability of PI3K-related protein kinases.	SMG1 TELO2 TP53	3.31e-05	10	230	3	18160036
Pubmed	FANCM connects the genome instability disorders Bloom's Syndrome and Fanconi Anemia.	FANCA FANCE TELO2	3.31e-05	10	230	3	20064461
Pubmed	Evolutionary history and genome organization of DUF1220 protein domains.	NBPF14 NBPF8 NBPF9	3.31e-05	10	230	3	22973535
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	EPPK1 PIPOX UBE3A PI4KA ANK3 DSC3 KALRN KLC4 ATXN1L SNRNP200	3.88e-05	304	230	10	32235678
Pubmed	Basement membrane assembly of the integrin α8β1 ligand nephronectin requires Fraser syndrome-associated proteins.	LAMA1 FREM2 GRIP1 PAX2	3.89e-05	29	230	4	22613833
Pubmed	Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis.	PLK1 KIF20A	4.35e-05	2	230	2	12939256
Pubmed	TrkA induces apoptosis of neuroblastoma cells and does so via a p53-dependent mechanism.	NTRK1 TP53	4.35e-05	2	230	2	15961390
Pubmed	Gene signatures associated with mouse postnatal hindbrain neural stem cells and medulloblastoma cancer stem cells identify novel molecular mediators and predict human medulloblastoma molecular classification.	PTCH1 TP53	4.35e-05	2	230	2	22628409
Pubmed	FBXO2 Promotes Proliferation of Endometrial Cancer by Ubiquitin-Mediated Degradation of FBN1 in the Regulation of the Cell Cycle and the Autophagy Pathway.	FBXO2 FBN1	4.35e-05	2	230	2	32984335
Pubmed	The expression of p53-induced protein with death domain (Pidd) and apoptosis in oral squamous cell carcinoma.	PIDD1 TP53	4.35e-05	2	230	2	17437012
Pubmed	Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma.	TNKS TP53	4.35e-05	2	230	2	23800953
Pubmed	Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector.	PTCH1 TP53	4.35e-05	2	230	2	20624968
Pubmed	Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6.	ACP6 TP53	4.35e-05	2	230	2	30914657
Pubmed	Cell-Cycle-Specific Function of p53 in Fanconi Anemia Hematopoietic Stem and Progenitor Cell Proliferation.	FANCA TP53	4.35e-05	2	230	2	29307578
Pubmed	DNA damage stress induces the expression of ribosomal protein S27a gene in a p53-dependent manner.	RPS27A TP53	4.35e-05	2	230	2	25592822
Pubmed	The methyltransferase SETD6 regulates Mitotic progression through PLK1 methylation.	SETD6 PLK1	4.35e-05	2	230	2	30622182
Pubmed	Surface plasmon resonance imaging protein arrays for analysis of triple protein interactions of HPV, E6, E6AP, and p53.	UBE3A TP53	4.35e-05	2	230	2	16493710
Pubmed	Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists.	PTCH1 TP53	4.35e-05	2	230	2	23291299
Pubmed	Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia.	FANCA TP53	4.35e-05	2	230	2	36191479
Pubmed	RGS14 is a mitotic spindle protein essential from the first division of the mammalian zygote.	RGS12 RGS14	4.35e-05	2	230	2	15525537
Pubmed	Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53.	UBE3A TP53	4.35e-05	2	230	2	8380895
Pubmed	p53-dependent repression of polo-like kinase-1 (PLK1).	PLK1 TP53	4.35e-05	2	230	2	20962589
Pubmed	Uhrf1 regulates active transcriptional marks at bivalent domains in pluripotent stem cells through Setd1a.	SETD1A UHRF1	4.35e-05	2	230	2	29968706
Pubmed	Kalirin and Trio proteins serve critical roles in excitatory synaptic transmission and LTP.	TRIO KALRN	4.35e-05	2	230	2	26858404
Pubmed	Rhabdomyosarcoma--working out the pathways.	PTCH1 TP53	4.35e-05	2	230	2	10498887
Pubmed	DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer.	DSC3 TP53	4.35e-05	2	230	2	21364582
Pubmed	A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.	UBE3A TP53	4.35e-05	2	230	2	1661671
Pubmed	Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcom.	PLK1 TP53	4.35e-05	2	230	2	22405092
Pubmed	The ubiquitin ligase RNF126 regulates the retrograde sorting of the cation-independent mannose 6-phosphate receptor.	RNF126 IGF2R	4.35e-05	2	230	2	24275455
Pubmed	Acidic glycosaminoglycans and laminin-1 in renal corpuscles of mutant blebs (my) and control mice.	LAMA1 FREM2	4.35e-05	2	230	2	9302549
Pubmed	Setd1a Plays Pivotal Roles for the Survival and Proliferation of Retinal Progenitors via Histone Modifications of Uhrf1.	SETD1A UHRF1	4.35e-05	2	230	2	33938913
Pubmed	Disruption of the presynaptic cytomatrix protein bassoon degrades ribbon anchorage, multiquantal release, and sound encoding at the hair cell afferent synapse.	BSN CACNA1D	4.35e-05	2	230	2	23467361
Pubmed	MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.	KMT2C TP53	4.35e-05	2	230	2	24794707
Pubmed	DNA methylation promotes paired box 2 expression via myeloid zinc finger 1 in endometrial cancer.	MZF1 PAX2	4.35e-05	2	230	2	27764784
Pubmed	Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.	PTCH1 TP53	4.35e-05	2	230	2	28714964
Pubmed	Developmental refinement of hair cell synapses tightens the coupling of Ca2+ influx to exocytosis.	BSN CACNA1D	4.35e-05	2	230	2	24442635
Pubmed	Tumor Suppressor p53 Inhibits Hepatitis B Virus Replication by Downregulating HBx via E6AP-Mediated Proteasomal Degradation in Human Hepatocellular Carcinoma Cell Lines.	UBE3A TP53	4.35e-05	2	230	2	36298868
Pubmed	mTORC1 promotes malignant large cell/anaplastic histology and is a targetable vulnerability in SHH-TP53 mutant medulloblastoma.	PTCH1 TP53	4.35e-05	2	230	2	34673573
Pubmed	The human E6-AP gene (UBE3A) encodes three potential protein isoforms generated by differential splicing.	UBE3A TP53	4.35e-05	2	230	2	9143503
Pubmed	Latent TGF-β binding protein 4 promotes elastic fiber assembly by interacting with fibulin-5.	LTBP4 FBLN5	4.35e-05	2	230	2	23382201
Pubmed	HIV-1 Nef promotes ubiquitination and proteasomal degradation of p53 tumor suppressor protein by using E6AP.	UBE3A TP53	4.35e-05	2	230	2	32819562
Pubmed	PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression.	DUSP2 TP53	4.35e-05	2	230	2	12673251
Pubmed	Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53.	UBE3A TP53	4.35e-05	2	230	2	26789255
Pubmed	A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase.	UBE3A TP53	4.35e-05	2	230	2	7708685
Pubmed	Noncanonical activation of GLI signaling in SOX2+ cells drives medulloblastoma relapse.	PTCH1 TP53	4.35e-05	2	230	2	35857834
Pubmed	Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation.	PLK1 TP53	4.35e-05	2	230	2	15024021
Pubmed	Ubiquitin E3 ligase UHRF1 regulates p53 ubiquitination and p53-dependent cell apoptosis in clear cell Renal Cell Carcinoma.	UHRF1 TP53	4.35e-05	2	230	2	26102039
Pubmed	Differential expression of regulator of G-protein signaling R12 subfamily members during mouse development.	RGS12 RGS14	4.35e-05	2	230	2	16145674
Pubmed	Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit.	NFKB2 TP53	4.35e-05	2	230	2	16990795
Pubmed	The p53 target gene desmocollin 3 acts as a novel tumor suppressor through inhibiting EGFR/ERK pathway in human lung cancer.	DSC3 TP53	4.35e-05	2	230	2	22941060
Pubmed	UBE3A activates the NOTCH pathway and promotes esophageal cancer progression by degradation of ZNF185.	ZNF185 UBE3A	4.35e-05	2	230	2	34421347
Pubmed	Evasion of Cell Senescence Leads to Medulloblastoma Progression.	PTCH1 TP53	4.35e-05	2	230	2	26997276
Pubmed	Desmocollin 3-mediated binding is crucial for keratinocyte cohesion and is impaired in pemphigus.	DSC3 DSG1	4.35e-05	2	230	2	19717567
Pubmed	Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma.	PTCH1 TP53	4.35e-05	2	230	2	15480423
Pubmed	Plakins in development and disease.	EPPK1 PLEC	4.35e-05	2	230	2	17499243
Pubmed	Essential role of microfibrillar-associated protein 4 in human cutaneous homeostasis and in its photoprotection.	MFAP4 FBN1	4.35e-05	2	230	2	22355679
Pubmed	SETD1A induced miRNA network suppresses the p53 gene expression module.	SETD1A TP53	4.35e-05	2	230	2	26865005
Pubmed	HPV16 E6 confers p53-dependent and p53-independent phenotypes in the epidermis of mice deficient for E6AP.	UBE3A TP53	4.35e-05	2	230	2	17130828
Interaction	ZNF408 interactions	LAMA1 NOTCH2NLA RPS27A NBPF19 FBN1 FHL2 LTBP4 FBLN5 KIF20A SPRED1	5.46e-06	145	225	10	int:ZNF408
Interaction	LAMA5 interactions	PTCH1 FBXO2 CFD MFAP4 FBN1 OS9 PLEC FBLN5 OBSL1	6.68e-06	117	225	9	int:LAMA5
Interaction	ATN1 interactions	SETD1A ZSWIM8 SSPOP CFD KMT2C LTBP4 FBLN5 CASP8 SLIT1 KAT6B TP53	8.56e-06	187	225	11	int:ATN1
Interaction	FAAP24 interactions	FANCA ATRIP TELO2 EME2 TP53	9.01e-06	26	225	5	int:FAAP24
Interaction	SHANK3 interactions	ACP6 NES NOTCH2NLA RPS27A TASOR2 CLU PI4KA IGSF9 LTBP4 VPS18 ZAN ANK3 KALRN RGS14 IGF2R MACF1 ZFHX3 TP53	1.26e-05	496	225	18	int:SHANK3
Interaction	PCDHGA8 interactions	PCDHGA9 PCDHGA5 PCDHGA8	1.35e-05	5	225	3	int:PCDHGA8
Interaction	FKBP5 interactions	HGH1 RPS6KB2 PIPOX PI4KA DDX18 RECQL4 PLD2 AMHR2 TUT4 COL6A6 NTRK1 DUSP2 LRRK1 XRCC3 PRKCQ TP53	1.80e-05	414	225	16	int:FKBP5
Interaction	KLK5 interactions	CLSTN3 FBXO2 FREM2 OAF PI4KA OS9 DSG1 CASP8	3.08e-05	109	225	8	int:KLK5
Interaction	TOP3B interactions	SETD1A RAPGEF6 EPPK1 TRIO PIEZO1 PFAS PTCH1 PLEKHH3 ITPR3 FANCA KMT2C PI4KA NFKB2 PLA2G6 MICAL3 PLEC CHPF LTBP4 GAREM1 FBLN5 EP400 KALRN HIP1R LRRK1 IPO4 PHC2 CTDSP2 MST1R IGF2R EPOP HELZ2 ZFYVE26 PAX2 TP53	4.06e-05	1470	225	34	int:TOP3B
Cytoband	5q31	PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 KIF20A PCDHGA8	2.00e-06	115	230	7	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	RAPGEF6 SRA1 PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 KIF20A CYSTM1 PCDHGA8	3.05e-06	298	230	10	chr5q31
Cytoband	18q12.1	GAREM1 DSC3 DSG1 DSG4	8.41e-06	26	230	4	18q12.1
Cytoband	1q21.1	NBPF14 HJV NBPF8 NBPF9 NBPF10	1.55e-05	62	230	5	1q21.1
Cytoband	Ensembl 112 genes in cytogenetic band chr1q21	ACP6 NOTCH2NLA NOTCH2NLC NBPF19 NBPF14 HJV NBPF20 NBPF9 NBPF10 PBXIP1	4.20e-05	404	230	10	chr1q21
Cytoband	19p13.3	CFD PLEKHJ1 RNF126 MISP UHRF1 ANKRD24 ARHGAP45	2.08e-04	237	230	7	19p13.3
Cytoband	2q35	ZFAND2B CHPF WNT6 OBSL1	6.87e-04	79	230	4	2q35
Cytoband	Ensembl 112 genes in cytogenetic band chr15q15	ANKRD63 SPTBN5 STRC STRCP1 VPS18	9.06e-04	147	230	5	chr15q15
GeneFamily	Neuroblastoma breakpoint family	NBPF26 NBPF19 NBPF14 NBPF8 NBPF20 NBPF9 NBPF10	7.76e-10	23	159	7	662
GeneFamily	Clustered protocadherins	PCDHGA9 PCDHGA6 PCDHGA5 PCDHB7 PCDHA13 PCDHGA8	2.07e-05	64	159	6	20
GeneFamily	Desmosomal cadherins	DSC3 DSG1 DSG4	2.28e-05	7	159	3	1188
GeneFamily	EF-hand domain containing\|Plakins	EPPK1 PLEC MACF1	3.62e-05	8	159	3	939
GeneFamily	CD molecules\|MRH domain containing	OS9 IGF2R	1.13e-03	6	159	2	1233
GeneFamily	Immunoglobulin like domain containing	PTK7 VSIG10L IGSF9 ISLR2 NTRK1 OBSL1 IGSF9B	1.62e-03	193	159	7	594
GeneFamily	LIM domain containing	ZNF185 MICAL3 FHL2 FBLIM1	1.80e-03	59	159	4	1218
GeneFamily	PDZ domain containing	RAPGEF6 CARD14 FRMPD1 RGS12 GRIP1 RHPN2	2.27e-03	152	159	6	1220
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	TRIO PTK7 IGSF9 KALRN OBSL1 IGSF9B	3.03e-03	161	159	6	593
Coexpression	NABA_CORE_MATRISOME	LAMA1 NYX SSPOP MFAP4 FBN1 LTBP4 COL6A2 FBLN5 COL6A6 EMILIN1 THBS2 SLIT1	4.79e-06	270	228	12	MM17057
Coexpression	JISON_SICKLE_CELL_DISEASE_DN	ERCC3 RPS27A ITPR3 TUT4 B4GAT1 DUSP2 RNF126 SRRT MZF1 SNRNP200	5.73e-06	186	228	10	M4911
Coexpression	NABA_CORE_MATRISOME	LAMA1 NYX SSPOP MFAP4 FBN1 LTBP4 COL6A2 FBLN5 COL6A6 EMILIN1 THBS2 SLIT1	5.78e-06	275	228	12	M5884
Coexpression	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	KDM5C PFAS PTK7 ITPR3 FANCA GRHPR PLEC B4GAT1 EP400 OBSL1 CTDSP2 IGF2R	5.99e-06	276	228	12	M3063
Coexpression	GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_UP	ACP6 PTCH1 NACAD RTN2 PI4KA KAZN PLD2 PHC2 IGF2R MZF1	9.09e-06	196	228	10	M7562
Coexpression	GSE17721_CTRL_VS_CPG_0.5H_BMDC_DN	FBN1 DDX18 RECQL4 CARD14 FBLN5 SRA1 RNF126 PHC2 RHPN2 ZFHX3	1.08e-05	200	228	10	M3755
Coexpression	GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_UP	PTCH1 IGSF9 TIMELESS STRC LRRK1 CTDSP2 RGS14 RNPEP ZFYVE26 MX2	1.08e-05	200	228	10	M4024
Coexpression	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7	RAPGEF6 ZNF185 PTCH1 RECQL4 SPOCD1 CACNA1D KALRN SAP30L MST1R CYSTM1 SPRED1 LONRF2 FAM131B TP53	1.18e-05	399	228	14	M2413
Coexpression	NABA_MATRISOME_BLEO_FIBROTIC_LUNG	MFAP4 COL6A2 FBLN5 EMILIN1	2.42e-05	20	228	4	MM17053
Coexpression	DESCARTES_FETAL_THYMUS_STROMAL_CELLS	MFAP4 FBN1 CHPF LTBP4 COL6A6 OBSL1 EMILIN1 THBS2	2.77e-05	137	228	8	M40313
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL	CLSTN3 TSPAN18 NBPF26 ITPR3 FREM2 TMEM106C IGSF9 PLEC AMHR2 VPS18 ANK3 DUSP2 OBSL1 NPEPL1 NXN NBPF20 PHC2 DHRS12 RHPN2 NBPF9 CYSTM1 CRB2	3.42e-05	955	228	22	M45680
Coexpression	BHAT_ESR1_TARGETS_VIA_AKT1_UP	ZNF185 ATRIP RECQL4 KAZN FHL2 DUSP2 XRCC3 PPARGC1B UHRF1 LONRF2 CYP4F11	3.86e-05	281	228	11	M2234
Coexpression	NABA_ECM_GLYCOPROTEINS	LAMA1 SSPOP MFAP4 FBN1 LTBP4 FBLN5 EMILIN1 THBS2 SLIT1	4.77e-05	191	228	9	MM17059
Coexpression	GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP	PIEZO1 GON4L ITGB7 DDX18 DSG1 RNF126 NBPF10 FAM131B TP53	5.60e-05	195	228	9	M3184
Coexpression	NABA_ECM_GLYCOPROTEINS	LAMA1 SSPOP MFAP4 FBN1 LTBP4 FBLN5 EMILIN1 THBS2 SLIT1	5.83e-05	196	228	9	M3008
Coexpression	GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN	WDR81 PLA2G6 CHST7 CTDSP2 RGS14 DHRS12 ZFYVE26 ARHGAP45 PBXIP1	6.81e-05	200	228	9	M8620
Coexpression	GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_UP	NHSL2 NYX ABCG4 ATXN1L CTDSP2 MST1R KLF7 ZFYVE26 PBXIP1	6.81e-05	200	228	9	M8469
Coexpression	GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN	GON4L EME2 ANAPC7 KLC4 ATXN1L RGS12 HELZ2 ZFYVE26 PBXIP1	6.81e-05	200	228	9	M6208
Coexpression	GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_DN	PLEKHH3 OS9 C2 KAZN RNF169 SRA1 NXN PHC2 UHRF1	6.81e-05	200	228	9	M5088
Coexpression	CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL	MFAP4 FBN1 LTBP4 COL6A2 FBLN5 COL6A6 THBS2	7.58e-05	117	228	7	M39300
Coexpression	CHANDRAN_METASTASIS_UP	SMG1 TRIO KMT2C NBPF14 EP400 THBS2 LONRF2 TMCC1 CRB2	9.53e-05	209	228	9	M16036
Coexpression	MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD	FBN1 FHL2 SPOCD1 NXN THBS2 KLF7 FIBCD1	1.15e-04	125	228	7	M38988
Coexpression	IBRAHIM_NRF2_DOWN	MANBA PIDD1 PLEKHH3 FANCE RECQL4 OBSL1 KIF20A PBXIP1	1.17e-04	168	228	8	M42513
Coexpression	HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL	MFAP4 OAF CLU TXNL4B FHL2 LTBP4 TBX1 ISLR2 TSPAN11 KALRN EMILIN1 PPARGC1B	1.42e-04	382	228	12	M45756
Coexpression	DESCARTES_FETAL_EYE_STROMAL_CELLS	FBN1 LTBP4 COL6A2 COL6A6 EMILIN1 THBS2	1.46e-04	91	228	6	M40180
Coexpression	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP	PIEZO1 PIDD1 PTK7 GRHPR RNF169 RNF126 IGF2R DCXR	1.68e-04	177	228	8	M5681
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	SMG1 SETD1A TRIO NHSL2 KDM5C KMT2C UBE3A PLEC LTBP4 GAREM1 COL6A2 AMHR2 TUT4 OBSL1 CPD EMILIN1 COA8 IGF2R ZKSCAN3 SPRED1 ZFHX3 GALNT5 FBLIM1	1.05e-05	801	220	23	gudmap_developingGonad_e14.5_ epididymis_1000
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	LAMA1 PTCH1 PTK7 CFD MFAP4 FBN1 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 NRIP3 EMILIN1 MACF1	2.69e-12	200	229	14	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	CLSTN3 PTK7 CFD MFAP4 FBN1 CLU NFKB2 LTBP4 COL6A2 COL6A6 NRIP3 EMILIN1 FBLIM1	3.92e-11	199	229	13	fde2b65afde69f402f1b7b056eaa266e9fd5b227
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	LAMA1 PTCH1 PTK7 CFD MFAP4 FBN1 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 MACF1	5.63e-10	199	229	12	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PTK7 CFD MFAP4 FBN1 FHL2 LTBP4 COL6A2 FBLN5 COL6A6 NRIP3 EMILIN1 MACF1	5.63e-10	199	229	12	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PTK7 CFD MFAP4 FBN1 FHL2 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 NRIP3 MACF1	5.96e-10	200	229	12	b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PTK7 CFD MFAP4 FBN1 FHL2 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 NRIP3 MACF1	5.96e-10	200	229	12	50ca6550998e461ef26dd670351060bd940765a8
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	LAMA1 PTCH1 PTK7 CFD MFAP4 FBN1 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 MACF1	5.96e-10	200	229	12	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PTK7 CFD MFAP4 FBN1 FHL2 LTBP4 COL6A2 FBLN5 COL6A6 NRIP3 MACF1 FBLIM1	5.96e-10	200	229	12	3bdba9612cd7c612b76aa9abecc4a6529aabfc1c
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PTK7 CFD MFAP4 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 NRIP3 EMILIN1 THBS2	4.57e-09	190	229	11	d60395739458d7f47a3350ade751fe3819500320
ToppCell	wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	DCHS2 TRIO MFAP4 FBN1 OAF CHPF LTBP4 COL6A2 FBLN5 COL6A6 THBS2	7.40e-09	199	229	11	8de6d7b2067b22cb9b5f01aa56a3803aebc4406d
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	PTK7 CFD MFAP4 FBN1 OAF LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 MACF1	7.40e-09	199	229	11	c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PTCH1 PTK7 CFD MFAP4 FBN1 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 MACF1	7.40e-09	199	229	11	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	PTCH1 PTK7 CFD MFAP4 FBN1 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 MACF1	7.80e-09	200	229	11	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	cellseq-Mesenchymal-Fibroblastic\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFD MFAP4 FBN1 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 EMILIN1 THBS2 MACF1	7.80e-09	200	229	11	8978867bf69c830b1e48cac2ad6b512dbe60f149
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PTK7 CFD MFAP4 FBN1 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 NRIP3 MACF1	7.80e-09	200	229	11	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	PTCH1 PTK7 CFD MFAP4 FBN1 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 MACF1	7.80e-09	200	229	11	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PTK7 CFD MFAP4 FBN1 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 NRIP3 MACF1	7.80e-09	200	229	11	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	PTCH1 PTK7 CFD MFAP4 FBN1 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 MACF1	7.80e-09	200	229	11	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RTN2 MFAP4 CHPF LTBP4 COL6A2 FBLN5 EMILIN1 KIF20A THBS2 FBLIM1	3.26e-08	179	229	10	b70509288aaf4457afd350f6c45784521337ce0d
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CFD MFAP4 FBN1 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 NRIP3 EMILIN1	5.45e-08	189	229	10	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTCH1 MFAP4 FBN1 FHL2 LTBP4 COL6A2 FBLN5 KALRN EMILIN1 FBLIM1	6.32e-08	192	229	10	bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFD MFAP4 FBN1 FHL2 COL6A2 FBLN5 EMILIN1 THBS2 GALNT5 FBLIM1	6.32e-08	192	229	10	f88aba74d6e8c594c32fe2bc095b5da28b4b28e9
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CFD MFAP4 FBN1 LTBP4 CACNA1D COL6A2 COL6A6 NRIP3 EMILIN1 THBS2	6.32e-08	192	229	10	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTCH1 MFAP4 FBN1 FHL2 LTBP4 COL6A2 FBLN5 KALRN EMILIN1 FBLIM1	6.32e-08	192	229	10	0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFD MFAP4 FBN1 FHL2 COL6A2 FBLN5 EMILIN1 THBS2 GALNT5 FBLIM1	6.32e-08	192	229	10	41a8326cd5bc19ad5041068501bab4c72399222e
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MFAP4 FBN1 OAF C2 CHPF LTBP4 COL6A2 FBLN5 TSPAN11 NTRK1	6.97e-08	194	229	10	c9e589fe7df6a9b377654581a2aebb607cbb03b9
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PTCH1 MFAP4 FBN1 MICAL3 KAZN CACNA1D FBLN5 COL6A6 EMILIN1 FBLIM1	6.97e-08	194	229	10	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTCH1 FBN1 FHL2 LTBP4 COL6A2 FBLN5 KALRN EMILIN1 THBS2 FBLIM1	6.97e-08	194	229	10	e03ba6caed59fa64d4d9b042593469d4a6a3dc10
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFD MFAP4 FBN1 FHL2 LTBP4 COL6A2 FBLN5 EMILIN1 THBS2 GALNT5	7.31e-08	195	229	10	47762d9e442fb1f6f0033e3e10f4c6e498d2c081
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFD MFAP4 FBN1 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 EMILIN1 MACF1	7.31e-08	195	229	10	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFD MFAP4 FBN1 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 EMILIN1 MACF1	7.31e-08	195	229	10	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	droplet-Bladder-nan-3m-Epithelial-bladder_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MFAP4 FBN1 OAF CHPF LTBP4 COL6A2 FBLN5 EMILIN1 THBS2 FBLIM1	7.67e-08	196	229	10	f47e551ba484687ba6ce8c29a085106131364042
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFD MFAP4 FBN1 LTBP4 COL6A2 FBLN5 COL6A6 EMILIN1 THBS2 MACF1	7.67e-08	196	229	10	42e9828222a9663525d571633e8a454c30bfa7f8
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NES TRIO FREM2 CLU CHPF SPOCD1 COL6A2 EMILIN1 FBLIM1 LONRF2	7.67e-08	196	229	10	b8b9801181d7604871b48aebacb295d0a57a5eaf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTCH1 FBN1 FHL2 LTBP4 COL6A2 FBLN5 KALRN EMILIN1 THBS2 FBLIM1	8.04e-08	197	229	10	ae0435f4b4a9cdedb1c201fc56921048390097bf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PTCH1 FBN1 FHL2 LTBP4 COL6A2 FBLN5 KALRN EMILIN1 THBS2 FBLIM1	8.04e-08	197	229	10	37f6b6f2809b952382eaebb642b0aad6371f4251
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Mesothelial-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CFD FBN1 OAF CLU BSN LTBP4 COL6A2 PCDHGA9 EMILIN1 THBS2	8.43e-08	198	229	10	2dc0510846cbc296a300b8465e7be9b39f479852
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	NES PTCH1 CLU INSC SPOCD1 COL6A2 TSPAN11 EMILIN1 THBS2 GALNT5	8.43e-08	198	229	10	6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Mesothelial-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CFD FBN1 OAF CLU BSN LTBP4 COL6A2 PCDHGA9 EMILIN1 THBS2	8.43e-08	198	229	10	eb7e674d08a7aeb554c1e4797338280581b79989
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFD MFAP4 FBN1 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 EMILIN1 MACF1	8.43e-08	198	229	10	f1374f7a50244d59c766ac41f44c08c9117407d2
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PTCH1 PTK7 MFAP4 FBN1 KAZN FHL2 LTBP4 COL6A2 EMILIN1 FBLIM1	8.43e-08	198	229	10	09be07ebfc3e49c3858e9b74605b69cf4fc28b56
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Mesothelial-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CFD FBN1 OAF CLU BSN LTBP4 COL6A2 PCDHGA9 EMILIN1 THBS2	8.43e-08	198	229	10	364de83e30d842123fb92367f54b4bea57a47c84
ToppCell	LPS_only-Mesenchymal_fibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	PTK7 CFD MFAP4 FBN1 CLU LTBP4 COL6A2 COL6A6 NRIP3 FBLIM1	8.84e-08	199	229	10	211c3a08f2d484ab7a3368006767289088f0d957
ToppCell	368C-Fibroblasts\|368C / Donor, Lineage, Cell class and subclass (all cells)	CFD MFAP4 FBN1 OAF CLU LTBP4 COL6A2 FBLN5 EMILIN1 THBS2	8.84e-08	199	229	10	dbf64b83e2dc311b68f299c3f306ee098efd664c
ToppCell	(5)_Fibroblast-D\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	CFD MFAP4 FBN1 OAF LTBP4 COL6A2 FBLN5 EMILIN1 THBS2 SLIT1	8.84e-08	199	229	10	3f415620ad8b8d8c6871e1353e13f87b281fcc0e
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	MFAP4 FBN1 KAZN LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 EMILIN1 THBS2	8.84e-08	199	229	10	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PTK7 CFD MFAP4 FBN1 FHL2 LTBP4 COL6A2 FBLN5 COL6A6 NRIP3	8.84e-08	199	229	10	38ed3bc7daa993d9edcf3e7834597ebb06dd24f8
ToppCell	ILEUM-non-inflamed-(8)_Fibroblasts\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PTCH1 CFD MFAP4 FBN1 FHL2 LTBP4 COL6A2 FBLN5 EMILIN1 SLIT1	8.84e-08	199	229	10	d9d7f36b4b5592b7855448730044c90997b55499
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF185 MFAP4 OAF INSC CHPF COL6A2 FBLN5 EMILIN1 THBS2 ZFHX3	8.84e-08	199	229	10	edd5300da1a3b758210ff8f949e9d1988b8bc7e2
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFD MFAP4 FBN1 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 EMILIN1 MACF1	8.84e-08	199	229	10	66a79732caf2f04c09b4d9832377aa01ca477677
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts\|LPS_only / Treatment groups by lineage, cell group, cell type	PTK7 CFD MFAP4 FBN1 CLU LTBP4 COL6A2 COL6A6 NRIP3 FBLIM1	8.84e-08	199	229	10	1a0add79f4e34078b3475eb11c85a4234bda197c
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	PTK7 CFD MFAP4 FBN1 FHL2 LTBP4 COL6A2 FBLN5 NRIP3 FBLIM1	9.26e-08	200	229	10	ab4fda0cc95cb8f80ea9f28745013f3248def820
ToppCell	normal_Lung-Fibroblasts\|normal_Lung / Location, Cell class and cell subclass	CFD MFAP4 FBN1 OAF CLU LTBP4 COL6A2 FBLN5 EMILIN1 THBS2	9.26e-08	200	229	10	803cf7f1382d07220249029cd220233232027689
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PTCH1 CFD MFAP4 FBN1 C2 FHL2 LTBP4 COL6A2 FBLN5 EMILIN1	9.26e-08	200	229	10	c5d818203bef80ff97c2e0158cf61970673dd258
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFD MFAP4 FBN1 OAF LTBP4 COL6A2 FBLN5 TSPAN11 EMILIN1 THBS2	9.26e-08	200	229	10	44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CFD MFAP4 FBN1 OAF CLU LTBP4 COL6A2 FBLN5 EMILIN1 THBS2	9.26e-08	200	229	10	ef30f9b68bfdb8d947ed399603e4dd0d5ff0144d
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CFD MFAP4 FBN1 OAF CLU LTBP4 COL6A2 FBLN5 EMILIN1 THBS2	9.26e-08	200	229	10	b28bfe6eb96b4db9cb27f0fc8fc39259c125f05e
ToppCell	Fibroblast\|World / shred by cell class for parenchyma	CFD MFAP4 FBN1 OAF LTBP4 COL6A2 FBLN5 EMILIN1 THBS2 SLIT1	9.26e-08	200	229	10	dec9ce1bc2571197003596f32e5f742ede72aa79
ToppCell	Lung_Parenchyma-Control-Mesenchymal\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CFD MFAP4 FBN1 OAF CLU LTBP4 COL6A2 FBLN5 EMILIN1 THBS2	9.26e-08	200	229	10	1e75d1302c22e1b1666c19c0c9259d5cc8be16d5
ToppCell	cellseq2-Mesenchymal-Fibroblastic\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFD MFAP4 FBN1 OAF LTBP4 COL6A2 FBLN5 TSPAN11 EMILIN1 THBS2	9.26e-08	200	229	10	1c10597edd532bf172ca09870a937d35e2585081
ToppCell	Parenchyma_Control_(B.)-Stromal-TX\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CFD MFAP4 FBN1 OAF CLU LTBP4 COL6A2 FBLN5 EMILIN1 THBS2	9.26e-08	200	229	10	0a86656d48e4238d0e4d592d477d29f7ba7c2ec0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CFD MFAP4 FBN1 OAF CLU LTBP4 COL6A2 FBLN5 EMILIN1 THBS2	9.26e-08	200	229	10	3fa7d9ea67f9cc55478d085da53babd03dbe9bb1
ToppCell	normal_Lung-Fibroblasts-COL14A1+_matrix_FBs\|normal_Lung / Location, Cell class and cell subclass	CFD MFAP4 FBN1 OAF CLU LTBP4 COL6A2 FBLN5 EMILIN1 THBS2	9.26e-08	200	229	10	ee3d06865a6300e1279edf6664320b71647f5efb
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFD MFAP4 FBN1 OAF LTBP4 COL6A2 FBLN5 TSPAN11 EMILIN1 THBS2	9.26e-08	200	229	10	440dda48b09c6a8581b7ca634b0d67f1ecacf65e
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CFD MFAP4 FBN1 OAF CLU LTBP4 COL6A2 FBLN5 EMILIN1 THBS2	9.26e-08	200	229	10	87953ea65ff2a01485e13dd49d993ae6ae679cbf
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ZNF185 LAMA1 MFAP4 C2 COL6A2 FBLN5 WNT6 EMILIN1 THBS2	3.74e-07	178	229	9	cda7695411655bd6d0ba69e5041ca7530a9dad3a
ToppCell	LA-01._Fibroblast_I\|LA / Chamber and Cluster_Paper	CFD FBN1 KAZN LTBP4 COL6A2 FBLN5 COL6A6 NTRK1 ZFHX3	3.92e-07	179	229	9	dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Gpr139\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CCDC88B PTK7 SPTBN5 ISLR2 COL6A2 WNT9B EMILIN1 ZFHX3	4.79e-07	134	229	8	917b8951dd4c870b6b92f2e73e02dac884330c30
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFD MFAP4 FBN1 LTBP4 COL6A2 FBLN5 COL6A6 EMILIN1 THBS2	5.42e-07	186	229	9	5473283fb95cee556b1f6934cf72169b676b5bcc
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFD MFAP4 FBN1 CLU LTBP4 COL6A2 FBLN5 EMILIN1 THBS2	5.42e-07	186	229	9	07d94d5d1c2fe7bb909a07ca81058a0eabc65c60
ToppCell	droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA1 CHPF COL6A2 FBLN5 ANK3 PCDHB7 NRIP3 SYDE1 THBS2	5.67e-07	187	229	9	b6ecf55014f246461bf1ca12f24cb4d046661fa4
ToppCell	droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA1 CHPF COL6A2 FBLN5 ANK3 PCDHB7 NRIP3 SYDE1 THBS2	5.67e-07	187	229	9	9fb15f24b9b364b0c4704ec98aec236eaec5411c
ToppCell	droplet-Liver-HEPATOCYTES-1m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA1 CHPF COL6A2 FBLN5 ANK3 PCDHB7 NRIP3 SYDE1 THBS2	5.67e-07	187	229	9	e6afbaed352310a1cb49571a2aae18be1f533c9a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 PTCH1 FBN1 FHL2 LTBP4 COL6A2 FBLN5 EMILIN1 FBLIM1	6.19e-07	189	229	9	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CFD MFAP4 FBN1 LTBP4 CACNA1D COL6A2 NRIP3 EMILIN1 THBS2	6.19e-07	189	229	9	e9d5e858e320c6e9913c1ea6a54967d21eda605f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 PTCH1 FBN1 FHL2 LTBP4 COL6A2 FBLN5 EMILIN1 FBLIM1	6.19e-07	189	229	9	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	PTCH1 PTK7 MFAP4 FBN1 CACNA1D COL6A2 FBLN5 MACF1 FBLIM1	6.19e-07	189	229	9	dc5164591dea45b420798b94dda211be03daa70c
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PTCH1 MFAP4 FBN1 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 EMILIN1	6.19e-07	189	229	9	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	PTCH1 PTK7 MFAP4 FBN1 CACNA1D COL6A2 FBLN5 MACF1 FBLIM1	6.47e-07	190	229	9	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MFAP4 FBN1 LTBP4 CACNA1D COL6A2 COL6A6 NRIP3 EMILIN1 THBS2	6.76e-07	191	229	9	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBN1 OAF C2 CHPF COL6A2 FBLN5 TSPAN11 NTRK1 THBS2	6.76e-07	191	229	9	2b73fcd592d16cae8ded5e45c8fbf2d9adc8caad
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	PTK7 MFAP4 FBN1 MICAL3 LTBP4 CACNA1D COL6A2 IGF2R MACF1	6.76e-07	191	229	9	3379d145d34f89150f7b06d1340022cfc6b4a6ce
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CFD MFAP4 FBN1 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 EMILIN1	7.07e-07	192	229	9	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MFAP4 FBN1 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 NRIP3 EMILIN1	7.07e-07	192	229	9	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MFAP4 FBN1 MICAL3 LTBP4 CACNA1D COL6A2 EMILIN1 MACF1 FBLIM1	7.07e-07	192	229	9	e79f2253e084a9ab9afcaf7ec42a5012ade42d36
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PTK7 MFAP4 FBN1 LTBP4 CACNA1D COL6A2 FBLN5 COL6A6 EMILIN1	7.07e-07	192	229	9	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	facs-Lung-EPCAM-18m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 OAF C2 CHPF LTBP4 COL6A2 FBLN5 TSPAN11 THBS2	7.38e-07	193	229	9	92048d2e9e43513e6185e09553be3ee47d7e5207
ToppCell	facs-Lung-EPCAM-18m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 OAF C2 CHPF LTBP4 COL6A2 FBLN5 TSPAN11 THBS2	7.38e-07	193	229	9	ac088c8f27b5b1888610e461ff45870ca60da886
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	NHSL2 MFAP4 FBN1 CACNA1D COL6A2 COL6A6 EMILIN1 THBS2 FBLIM1	7.38e-07	193	229	9	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBN1 OAF C2 CHPF LTBP4 COL6A2 FBLN5 TSPAN11 NTRK1	7.38e-07	193	229	9	e27885a9e1a2a3e165c5366d4cfcda05c5454483
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	NHSL2 MFAP4 FBN1 KAZN CACNA1D COL6A2 FBLN5 COL6A6 EMILIN1	7.38e-07	193	229	9	acad568621ed677031797b8c2e34dafea798d681
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RTN2 MFAP4 FBN1 MICAL3 CACNA1D COL6A2 EMILIN1 MACF1 FBLIM1	7.70e-07	194	229	9	f15e81ff12525523c62d13105cf264ea72205e2e
ToppCell	PND01-03-samps-Mesenchymal\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	PTCH1 PTK7 MFAP4 FBN1 CACNA1D COL6A2 IGF2R MACF1 FBLIM1	7.70e-07	194	229	9	4f9bd0ded0dde1df885850714f29e73e992539a5
ToppCell	facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTCH1 MFAP4 C2 CHPF COL6A2 FBLN5 TSPAN11 EMILIN1 THBS2	8.04e-07	195	229	9	18b01ab63ee1deae3cf29669d66fff9ca4efc5c4
ToppCell	IPF-Stromal-Fibroblast\|World / Disease state, Lineage and Cell class	MFAP4 FBN1 OAF CLU FHL2 LTBP4 COL6A2 FBLN5 THBS2	8.04e-07	195	229	9	9c32756edb54f0c211185d9a98073fe01fd1526a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FBN1 FHL2 LTBP4 COL6A2 FBLN5 KALRN EMILIN1 THBS2 FBLIM1	8.04e-07	195	229	9	edd4cd8402af81737b2074f9dce71cc6ab09be7e
ToppCell	E12.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TSPAN18 MFAP4 OAF INSC FHL2 COL6A2 ZFHX3 FBLIM1 PBXIP1	8.04e-07	195	229	9	bff7685784688425bebd78b0f284a6d4475a9415
ToppCell	droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MFAP4 OAF C2 CHPF COL6A2 FBLN5 TSPAN11 EMILIN1 THBS2	8.04e-07	195	229	9	095b8e0be385b6390420589124a95fa4ba3682ab
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MFAP4 ZNF469 FBN1 CHPF LTBP4 COL6A2 FBLN5 EMILIN1 THBS2	8.39e-07	196	229	9	525d6c8a277364e624e7cc586275f8a891436b57
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTCH1 MFAP4 FBN1 LTBP4 COL6A2 FBLN5 TSPAN11 EMILIN1 THBS2	8.39e-07	196	229	9	e7bfd4fb400ae0c473131d0fa306c26be08a6d03
Drug	(1)-Nipecotic acid [498-95-3]; Down 200; 31uM; HL60; HT_HG-U133A	ZSWIM8 KDM5C PIEZO1 PIDD1 PLA2G6 KAZN PLEC CHPF SAP30L IPO4 NPEPL1 TMCC1	5.95e-07	196	224	12	3121_DN
Drug	Flucytosine [2022-85-7]; Up 200; 31uM; HL60; HT_HG-U133A	ZNF185 CHGA ITPR3 PLEC CHST7 CARD14 ANK3 DSC3 LRRK1 XRCC3 PAX2 PBXIP1	6.99e-07	199	224	12	3073_UP
Drug	Chloropyramine hydrochloride [6170-42-9]; Up 200; 12.2uM; PC3; HT_HG-U133A	TRIO ITGB7 NFKB2 PLA2G6 LTBP4 LRRK1 SYDE1 RGS12 ZNF710 PAX2 SNRNP200	2.61e-06	187	224	11	4589_UP
Drug	Flumethasone [2135-17-3]; Up 200; 9.8uM; MCF7; HT_HG-U133A	BORCS6 PIDD1 PLA2G6 MICAL3 PLEC LTBP4 CASP8 XRCC3 RGS12 ZKSCAN3 TP53	4.11e-06	196	224	11	3410_UP
Drug	Dehydrocholic acid [81-23-2]; Up 200; 9.6uM; PC3; HT_HG-U133A	BORCS6 SETD1A PTCH1 SPTBN5 TUT4 DUSP2 RGS12 SRRT GUCA2A PAX2 HTR3B	4.31e-06	197	224	11	4620_UP
Drug	Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A	BORCS6 PIDD1 RTN2 SPTBN5 CARD14 KALRN OBSL1 SRRT RGS14 PRKCQ CYP4F11	4.31e-06	197	224	11	2328_UP
Drug	tetraethylenepentamine pentahydrochloride; Up 200; 100uM; MCF7; HG-U133A	SETD1A TRIO PTCH1 ABCG4 GRHPR UBE3A NFKB2 CARD14 PAX2 PBXIP1 MVD	4.75e-06	199	224	11	406_UP
Drug	fullerene C60	ACP6 TRIO SETD6 PIEZO1 PIPOX PFAS FBXO2 ITPR3 FREM2 MFAP4 TELO2 C2 PLA2G6 PLD2 BSN TBX1 HJV CACNA1D KLF11 KALRN PCDHGA5 HIP1R LRRK1 NXN RGS12 MMACHC PHC2 KLF7 RHPN2 HELZ2 UHRF1 PAX2 TP53	1.14e-05	1498	224	33	ctd:C069837
Drug	plakin	SPTBN5 PLEC DSC3 DSG1 MACF1 DSG4 DCXR	1.65e-05	82	224	7	CID000018752
Drug	Pesticides	NOTCH2NLA NBPF14 NBPF8 CACNA1D WNT9B NBPF20 IGF2R NBPF9 NBPF10	1.84e-05	150	224	9	ctd:D010575
Drug	rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	RTN2 FBXO2 CACNA1D DSC3 HIP1R RGS12 ZNF710 KLF7 MZF1 PBXIP1	2.26e-05	193	224	10	921_UP
Drug	procymidone	CHGA CLU BSN CACNA1B CACNA1D CPD GRIP1 IGF2R SLIT1	2.38e-05	155	224	9	ctd:C035988
Drug	deferoxamine mesylate salt; Down 200; 100uM; MCF7; HG-U133A	ZSWIM8 ERMP1 CFD KAZN PLK1 CASP8 ZNF710 KIF20A CDK5RAP2 RNF41	2.47e-05	195	224	10	573_DN
Drug	5279552; Down 200; 22uM; MCF7; HT_HG-U133A_EA	TRIO FANCE TELO2 DNAJC24 PLEC NPEPL1 SRRT DHRS12 ARHGAP45 MVD	2.58e-05	196	224	10	960_DN
Drug	LY 294002; Up 200; 10uM; HL60; HT_HG-U133A	NES ZSWIM8 TRIO RTN2 UBE3A NFKB2 PLD2 CHST7 GAREM1 OBSL1	2.70e-05	197	224	10	6198_UP
Drug	Suprofen [40828-46-4]; Down 200; 15.4uM; HL60; HT_HG-U133A	ITPR3 PLEC GAREM1 ANK3 FRMPD1 CASP8 SRRT ZFYVE26 KAT6B PBXIP1	2.70e-05	197	224	10	3005_DN
Drug	Ethoxyquin [91-53-2]; Up 200; 18.4uM; HL60; HT_HG-U133A	CLSTN3 RTN2 ITPR3 KALRN RGS12 DHRS12 ZFHX3 TNKS PAX2 PBXIP1	2.82e-05	198	224	10	2559_UP
Drug	Azacyclonol [115-46-8]; Up 200; 15uM; HL60; HG-U133A	PIPOX ABCG4 NFKB2 PLA2G6 PLD2 CHPF NPEPL1 RGS12 MST1R PAX2	2.82e-05	198	224	10	2020_UP
Drug	Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; MCF7; HT_HG-U133A	NYX FBN1 UBE3A CACNA1D COL6A2 WNT6 DUSP2 HIP1R PBXIP1 MX2	2.94e-05	199	224	10	3640_UP
Drug	Adrenosterone [382-45-6]; Down 200; 13.4uM; PC3; HT_HG-U133A	TRIO PTK7 FBN1 GAREM1 NPEPL1 SYDE1 RGS14 ZFHX3 PBXIP1 TMCC1	2.94e-05	199	224	10	5045_DN
Drug	Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; PC3; HT_HG-U133A	TRIO PTCH1 CFD TELO2 LTBP4 DSC3 NPEPL1 SYDE1 ZKSCAN3 USP6NL	2.94e-05	199	224	10	7384_UP
Drug	Linuron	RPS6KB2 CHGA BSN CACNA1B CACNA1D GRIP1 IGF2R SLIT1	4.02e-05	128	224	8	ctd:D008044
Drug	Dichlorodiphenyl Dichloroethylene	CHGA PTCH1 CLU BSN CACNA1B CACNA1D NTRK1 CASP8 GRIP1 IGF2R SLIT1 TP53	4.84e-05	302	224	12	ctd:D003633
Drug	6-deoxyerythronolide B	ACP6 FANCA FANCE RECQL4 C2 XRCC3 TP53	4.93e-05	97	224	7	CID000121904
Disease	nevus count, cutaneous melanoma	TASOR2 FANCA PLA2G6 CASP8 PPARGC1B TP53 MX2	4.77e-06	91	215	7	EFO_0000389, EFO_0004632
Disease	mental development measurement	PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA8	3.07e-05	25	215	4	EFO_0008230
Disease	HEPATOCELLULAR CARCINOMA	CASP8 IGF2R TP53	3.10e-05	9	215	3	114550
Disease	Hepatocellular carcinoma	CASP8 IGF2R TP53	3.10e-05	9	215	3	cv:C2239176
Disease	autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology)	STRC STRCP1	5.28e-05	2	215	2	DOID:0110471 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	ERCC3 RPS6KB2 DDX18 DNAJC24 TIMELESS PLD2 FHL2 SPOCD1 B4GAT1 DSC3 KALRN FRMPD1 CASP8 XRCC3 PPARGC1B MACF1 ZFYVE26 GALNT5 KAT6B TP53	1.26e-04	1074	215	20	C0006142
Disease	Cryptophthalmos syndrome	FREM2 GRIP1	1.58e-04	3	215	2	C0265233
Disease	cutis laxa (implicated_via_orthology)	LTBP4 FBLN5	1.58e-04	3	215	2	DOID:3144 (implicated_via_orthology)
Disease	prostate adenocarcinoma (biomarker_via_orthology)	CLU PRKCQ	1.58e-04	3	215	2	DOID:2526 (biomarker_via_orthology)
Disease	FRASER SYNDROME 1	FREM2 GRIP1	1.58e-04	3	215	2	C4551480
Disease	lymphocyte count	EPPK1 MANBA PIEZO1 ITGB7 ABCG4 ZNF469 FBN1 DDX18 NFKB2 PLA2G6 MICAL3 PLEC ZAN KALRN PCDHGA9 PCDHGA6 PCDHGA5 NTRK1 CASP8 NXN ZNF710 MST1R ARHGAP45 PCDHGA8	1.85e-04	1464	215	24	EFO_0004587
Disease	cutaneous melanoma	TASOR2 PLA2G6 CASP8 PPARGC1B TP53 MX2	2.67e-04	121	215	6	EFO_0000389
Disease	Schizophrenia	SETD1A RAPGEF6 TSPAN18 LAMA1 CHGA CLU PI4KA PLA2G6 TBX1 CACNA1B ANK3 NTRK1 RGS12 BLOC1S3 HTR3B ZNF565 TP53	2.79e-04	883	215	17	C0036341
Disease	Malignant Head and Neck Neoplasm	FANCA FANCE XRCC3 TP53	2.96e-04	44	215	4	C0278996
Disease	Fraser syndrome (implicated_via_orthology)	FREM2 GRIP1	3.14e-04	4	215	2	DOID:0090001 (implicated_via_orthology)
Disease	Immune dysregulation	NFKB2 CARD14	3.14e-04	4	215	2	C1844666
Disease	aspartate aminotransferase to alanine aminotransferase ratio	EPPK1 RECQL4 PLEC RGS12 UHRF1 CDK5RAP2 BLOC1S3 ARHGAP45	3.89e-04	239	215	8	EFO_0010934
Disease	BREAST CANCER	CASP8 XRCC3 TP53	4.61e-04	21	215	3	114480
Disease	sexual dimorphism measurement	RAPGEF6 EPPK1 RPS6KB2 PTCH1 FANCE SPTBN5 FBN1 PLEC BSN SPOCD1 CPD ZNF710 CTDSP2 SLIT1 MACF1 ZFHX3 TNKS PAX2 TP53	5.06e-04	1106	215	19	EFO_0021796
Disease	scoliosis (implicated_via_orthology)	SSPOP PTK7	5.21e-04	5	215	2	DOID:0060249 (implicated_via_orthology)
Disease	Granulomatous Slack Skin	NFKB2 PRKCQ TP53	5.30e-04	22	215	3	C0376407
Disease	C-reactive protein measurement	ZSWIM8 DCHS2 SSPOP PTK7 FANCA ZNF469 TXNL4B PLA2G6 MICAL3 PLD2 EME2 BSN USP47 ANK3 NPEPL1 MST1R MACF1 BLOC1S3 TNKS VSIG8	5.61e-04	1206	215	20	EFO_0004458
Disease	Sarcosine measurement	PCDHGA6 PCDHGA5 PCDHGA8	6.07e-04	23	215	3	EFO_0021668
Disease	Lymphoma, T-Cell, Cutaneous	NFKB2 PRKCQ TP53	6.07e-04	23	215	3	C0079773
Disease	Adenocarcinoma of large intestine	PTK7 PHKG1 NTRK1 PRKCQ TP53	7.00e-04	96	215	5	C1319315
Disease	non-melanoma skin carcinoma	CCDC88B FANCA ZNF469 C2 ZAN CASP8 PPARGC1B TP53	7.66e-04	265	215	8	EFO_0009260
Disease	Cutis Laxa	LTBP4 FBLN5	7.78e-04	6	215	2	C0010495
Disease	Bipolar Disorder	PLA2G6 TIMELESS CACNA1B CACNA1D ANK3 NTRK1 HIP1R CASP8 SRRT RNF41 HTR3B	8.07e-04	477	215	11	C0005586
Disease	breast cancer (is_implicated_in)	FANCA CLU CASP8 XRCC3 KAT6B TP53	8.36e-04	150	215	6	DOID:1612 (is_implicated_in)
Disease	Malignant neoplasm of skin	PTCH1 CASP8 XRCC3 TP53	9.12e-04	59	215	4	C0007114
Disease	Skin Neoplasms	PTCH1 CASP8 XRCC3 TP53	9.12e-04	59	215	4	C0037286
Disease	Malignant tumor of breast	CASP8 XRCC3 TP53	9.81e-04	27	215	3	cv:C0006142
Disease	Breast neoplasm	CASP8 XRCC3 TP53	9.81e-04	27	215	3	cv:C1458155
Disease	Familial cancer of breast	CASP8 XRCC3 TP53	9.81e-04	27	215	3	cv:C0346153
Disease	Pigmented Basal Cell Carcinoma	PTCH1 XRCC3 TP53	1.09e-03	28	215	3	C1368275
Disease	Carcinoma, Basal Cell	PTCH1 XRCC3 TP53	1.21e-03	29	215	3	C4721806
Disease	epilepsy (implicated_via_orthology)	TRIO KCNA7 UBE3A BSN CACNA1B KALRN	1.28e-03	163	215	6	DOID:1826 (implicated_via_orthology)
Disease	diastolic blood pressure, systolic blood pressure	PIDD1 PTK7 FBN1 FHL2 CACNA1D FBLN5 ANK3 SYDE1 RGS12 THBS2 KLF7 ZFHX3 TP53	1.35e-03	670	215	13	EFO_0006335, EFO_0006336
Disease	basal cell carcinoma (is_marker_for)	PTCH1 TP53	1.44e-03	8	215	2	DOID:2513 (is_marker_for)
Disease	Chronic pain	KAZN PRKCQ	1.44e-03	8	215	2	HP_0012532
Disease	multiple sclerosis	SETD1A EPPK1 MANBA CCDC88B PHKG1 OS9 PLEC DSG1 CASP8 RGS14 IGF2R ZFHX3	1.47e-03	594	215	12	MONDO_0005301
Disease	Leukemia, Myelocytic, Acute	TRIO FANCA FANCE KMT2C FHL2 TP53	1.74e-03	173	215	6	C0023467
Disease	keratinocyte carcinoma	CCDC88B FANCA CASP8 PPARGC1B TP53	1.76e-03	118	215	5	EFO_0010176
Disease	joint hypermobility measurement	PIEZO1 TUT4 THBS2	1.77e-03	33	215	3	EFO_0007905
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA8	1.82e-03	71	215	4	EFO_0007878, EFO_0007979
Disease	Liver Diseases, Parasitic	KMT2C TP53	1.84e-03	9	215	2	C0023897
Disease	retinal detachment (biomarker_via_orthology)	NTRK1 CASP8	1.84e-03	9	215	2	DOID:5327 (biomarker_via_orthology)
Disease	Adult Hepatocellular Carcinoma	CASP8 TP53	1.84e-03	9	215	2	C0279607
Disease	Colorectal Carcinoma	CLSTN3 LAMA1 KMT2C TBX1 VPS18 KALRN CASP8 NXN RHPN2 ZKSCAN3 LONRF2 SNRNP200 TP53	2.04e-03	702	215	13	C0009402
Disease	Inherited focal segmental glomerulosclerosis	PAX2 CRB2	2.29e-03	10	215	2	cv:CN327126
Disease	Focal segmental glomerulosclerosis	PAX2 CRB2	2.29e-03	10	215	2	cv:C0017668
Disease	attention deficit hyperactivity disorder, asthma	MANBA ITPR3	2.29e-03	10	215	2	EFO_0003888, MONDO_0004979
Disease	melanoma	FANCA PLA2G6 CASP8 TP53 MX2	2.35e-03	126	215	5	EFO_0000756
Disease	melanoma	ERCC3 CLU CASP8 XRCC3 USP6NL TP53 MX2	2.37e-03	248	215	7	C0025202
Disease	prostate carcinoma	TRIO TASOR2 UBE3A INSC BSN TBX1 WNT9B NVL CASP8 KLF7 ZFHX3 HTR3B PBXIP1 TP53 SEC14L5	2.38e-03	891	215	15	EFO_0001663
Disease	smoking cessation	ZSWIM8 ITPR3 BSN ANK3 CTDSP2 MST1R ZFHX3 TNKS	2.76e-03	325	215	8	EFO_0004319
Disease	Hereditary Nephrotic Syndromes, Autosomal Dominant	PAX2 CRB2	2.78e-03	11	215	2	cv:CN043612
Disease	Basal cell carcinoma	ERCC3 PTCH1	2.78e-03	11	215	2	C0007117
Disease	cancer	FANCA GRHPR C2 PLA2G6 FRMPD1 CASP8 ANKRD24 TP53 SEC14L5	2.80e-03	400	215	9	MONDO_0004992
Disease	Alzheimer disease	RAPGEF6 WDR81 CLU PLEC ANK3 SAP30L NXN EPOP PAX2 ARHGAP45	3.11e-03	485	215	10	MONDO_0004975
Disease	bronchopulmonary dysplasia (biomarker_via_orthology)	CASP8 TP53	3.32e-03	12	215	2	DOID:11650 (biomarker_via_orthology)
Disease	Pathological accumulation of air in tissues	FBLN5 TP53	3.32e-03	12	215	2	C0013990
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	ITPR3 ATXN1L	3.32e-03	12	215	2	DOID:1441 (implicated_via_orthology)
Disease	Charcot-Marie-Tooth disease (is_implicated_in)	ITPR3 FBLN5	3.32e-03	12	215	2	DOID:10595 (is_implicated_in)
Disease	basal cell carcinoma (is_implicated_in)	PTCH1 TP53	3.32e-03	12	215	2	DOID:2513 (is_implicated_in)
Disease	skin pigmentation measurement	PTCH1 FANCA FBN1 KALRN PPARGC1B	3.37e-03	137	215	5	EFO_0007009
Disease	mean platelet volume	FANCA PI4KA PLEC ZAN COL6A6 KALRN PCDHGA9 PCDHGA6 PCDHGA5 HIP1R RGS12 ZNF710 BLOC1S3 ARHGAP45 PCDHGA8 SEC14L5	3.45e-03	1020	215	16	EFO_0004584
Disease	information processing speed	INSC DSG1 SPRED1 ZFHX3	3.50e-03	85	215	4	EFO_0004363
Disease	apolipoprotein B measurement	DCHS2 WDR81 TXNL4B DDX18 PLEC AMHR2 ATXN1L RGS12 IGF2R BLOC1S3 ZFHX3 TP53	3.61e-03	663	215	12	EFO_0004615
Disease	Familial idiopathic steroid-resistant nephrotic syndrome	PAX2 CRB2	3.91e-03	13	215	2	cv:C4273714
Disease	HbA1c measurement	PIEZO1 ZNF185 PIPOX PFAS ABCG4 ATRIP TMEM106C BSN CASP8 MACF1 ARHGAP45 TP53	4.15e-03	675	215	12	EFO_0004541
Disease	esophagus squamous cell carcinoma (is_implicated_in)	FANCA KMT2C TP53	4.32e-03	45	215	3	DOID:3748 (is_implicated_in)
Disease	Fanconi anemia	FANCA FANCE	4.54e-03	14	215	2	cv:C0015625
Disease	chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology)	PI4KA TBX1	4.54e-03	14	215	2	DOID:0060413 (implicated_via_orthology)
Disease	age at last pregnancy measurement	MST1R LONRF2	4.54e-03	14	215	2	EFO_0009440
Disease	homocysteine measurement	DCHS2 FANCA MMACHC	4.60e-03	46	215	3	EFO_0004578
Disease	Osteosarcoma	RECQL4 MST1R TP53	4.89e-03	47	215	3	C0029463
Disease	nasopharynx carcinoma (is_implicated_in)	MST1R TP53	5.21e-03	15	215	2	DOID:9261 (is_implicated_in)
Disease	platelet-to-lymphocyte ratio	MANBA ITPR3 PLEC KALRN XRCC3 ZNF710 BLOC1S3 ARHGAP45	5.36e-03	363	215	8	EFO_0008446
Disease	lung adenocarcinoma (is_implicated_in)	PTCH1 KMT2C ZFHX3	5.49e-03	49	215	3	DOID:3910 (is_implicated_in)
Disease	worry measurement	PTCH1 KLF11 RGS12 CYSTM1 IGSF9B	5.52e-03	154	215	5	EFO_0009589
Disease	Intellectual Disability	SETD1A TRIO KDM5C LAMA1 GON4L KMT2C CACNA1B KLF7 MACF1	5.75e-03	447	215	9	C3714756
Disease	syndromic intellectual disability (implicated_via_orthology)	KDM5C ANAPC7	5.93e-03	16	215	2	DOID:0050888 (implicated_via_orthology)
Disease	idiopathic scoliosis (implicated_via_orthology)	SSPOP PTK7	5.93e-03	16	215	2	DOID:0060250 (implicated_via_orthology)
Disease	Adenoid Cystic Carcinoma	FANCA KMT2C UHRF1 TP53	6.23e-03	100	215	4	C0010606
Disease	Psychotic Disorders	PLA2G6 TBX1 ANK3 NTRK1	6.45e-03	101	215	4	C0033975

Protein segments in the cluster

Peptide	Gene	Start	Entry
LADLIGCQRLPEDQR	PRPF4B	956	Q13523
EERSCREELGQQHPR	CEP295NL	176	Q96MC4
ADDCPGDRESRKDLV	EP400	1016	Q96L91
ERGDLTCLEERCPFR	ABCG4	586	Q9H172
DLRCLEPEGAAELRL	RNPEP	66	Q9H4A4
DRILRVEAIDGDCSP	CLSTN3	161	Q9BQT9
APSLQDEVREAEAGR	CCDC88B	446	A6NC98
PENCCFLDRDIGRSL	BTBD16	306	Q32M84
REPGEFALLRSCQEV	B4GAT1	171	O43505
EQPFLCLRGDTDADR	HTR3B	336	O95264
AELPAACEEARQGLA	ANKRD24	886	Q8TF21
EAPARLCEGDTECRE	CACNA1B	271	Q00975
REARAQEPLVDGCSG	ERMP1	31	Q7Z2K6
RCFATDPDGLRELLE	AMHR2	471	Q16671
DRSIIDCRAEQGRTP	ANKRD63	36	C9JTQ0
GLCAAPREEKERETE	CDK5RAP2	261	Q96SN8
EDQILADPAEEQRCG	ISLR2	446	Q6UXK2
ECNCLPETVRRGTEL	NOTCH2NLA	206	Q7Z3S9
DTARRLCKEGLPVED	HJV	341	Q6ZVN8
FDREICLGIPDEASR	NVL	426	O15381
CLGIPDEASRERILQ	NVL	431	O15381
TAGRIDREELCAQSP	PCDHGA5	86	Q9Y5G8
TAGRIDREELCAQSP	PCDHGA8	86	Q9Y5G5
LVDDRCVVEPAAGDL	ITPR3	31	Q14573
EALLPQEENRREETC	KAT6B	1316	Q8WYB5
LAREGRLEDVENLGC	ANAPC7	281	Q9UJX3
QRVDRDVAPGTLCDV	CFD	136	P00746
LEECALRSRRQGTDP	KLC4	486	Q9NSK0
ESEALVLERDGPRCR	OBSL1	1031	O75147
QRCEDDLRNVGPVDA	DNAJC24	81	Q6P3W2
GCQSPEDTLVCRRDE	FAM47C	61	Q5HY64
LDAGDADPRRLCDLE	MISP	126	Q8IVT2
PNASVDVGDDVLLRC	NTRK1	201	P04629
DVGDDVLLRCQVEGR	NTRK1	206	P04629
TAGRIDREELCAQSP	PCDHGA6	86	Q9Y5G7
LRCAVLQLAEGGDDE	KLHL34	616	Q8N239
ARCLRDTEQIFREGP	PRKCQ	301	Q04759
CPAEGEAELELRVSE	MICAL3	1121	Q7RTP6
GDDDPQSRLEQCRLE	KAZN	751	Q674X7
LRIQDHCGDRDTPDS	KMT2C	3986	Q8NEZ4
PLQEAAADGCRESRV	ARHGAP45	1011	Q92619
DRGGARDLLEEACDQ	LRRK1	66	Q38SD2
QGPRCELDIDECASR	CRB2	101	Q5IJ48
SCDLDTLEPEHGNRR	KIAA0087	36	Q14695
ECEDGFILRGSPVRQ	C2	116	P06681
ERPERTVLGSRELCD	ATXN1L	606	P0C7T5
PGDRCAVSVLDNDAL	FREM2	101	Q5SZK8
RLRDACELESGTEPC	BSN	2561	Q9UPA5
CAALGTLLRDPREAE	DUSP2	11	Q05923
ADEDEGRPANDCLLI	DSG4	791	Q86SJ6
RNLLRNPCGEEDLEG	FBXO2	121	Q9UK22
TAGRIDREELCAQSP	PCDHGA9	86	Q9Y5G4
DGVRLAARIVDTPCN	NPEPL1	176	Q8NDH3
QADLDSLVRECPGIE	DCXR	41	Q7Z4W1
RLPQIARLDNGECVE	GAREM1	31	Q9H706
PVEELDREGQRLLQC	KALRN	241	O60229
IECIPDCTSRDQLGR	PI4KA	1896	P42356
RDNLAEELEGVAGRC	NES	81	P48681
LRRNPSCLGKGEEED	MACF1	11	O94854
EEDVGQPRLQACLRE	MVD	71	P53602
EPRRISETFGEDLDC	KLF7	46	O75840
GCDRAEPIAQRLEEG	LONRF2	16	Q1L5Z9
EALEIICSRGGDPDR	ANKS4B	46	Q8N8V4
ACPGRDRRTEEENLR	TP53	276	P04637
CTDVAARGLDIPEVD	DDX18	481	Q9NVP1
LQRLEEIAEDPGTCE	GUCA2A	91	Q02747
DCVPTRADRIALLEG	MMACHC	181	Q9Y4U1
ECNCLPETVRRGTEL	NOTCH2NLC	206	P0DPK4
ADEDEGRPSNDCLLI	DSG1	706	Q02413
EDAGCRDLESLSPRE	FAM131B	286	Q86XD5
DRLLAEGICDNDTVP	PAX2	116	Q02962
DVERAQRLRDCPGED	FAM74A7	66	A6NL05
ARREELLARGCPLEE	ITGB7	81	P26010
PGAEVCRVRATDRDL	DCHS2	311	Q6V1P9
TGQREEDSECLKEPR	PCDHA13	786	Q9Y5I0
LNEKLDREELCGPRE	PCDHB7	86	Q9Y5E2
DPADRLIDTCRECGA	HIP1R	716	O75146
CLETLPDFRDDRDGT	KCNA7	161	Q96RP8
SCGVVHRPEREALEN	BORCS6	66	Q96GS4
EAARQEEGDLDRAPC	CARD14	951	Q9BXL6
DTGNLFCTRPVDREE	DSC3	191	Q14574
DPVTDLLDRCGVFRA	CTDSP2	171	O14595
VEDQRRDELGPSTCL	CYSTM1	66	Q9H1C7
EDADVAACPRRGEEE	EPOP	106	A6NHQ4
IDECRISPDLCGRGQ	FBN1	1071	P35555
LSPRDEPRSDECGIN	FRMPD1	1076	Q5SYB0
RAIEDTRPAGCAEQL	GALNT5	476	Q7Z7M9
LLADRGDCDPEVSAA	FANCA	1421	O15360
IQERRCTLPTQGIDD	CYP4F11	271	Q9HBI6
DPRDDDLNLRALCDR	COL6A2	736	P12110
PAEGRVALARAADCE	GRHPR	16	Q9UBQ7
EAREEISGSPERDIC	GON4L	1331	Q3T8J9
LNPDGRERAQEKDCT	CPD	1036	O75976
CRDQAPAEDARGEII	DHRS12	71	A0PJE2
GLLDRLDDSPDQCRD	ANK3	4221	Q12955
AERLDIVAGCRLLPD	BLOC1S3	171	Q6QNY0
CQSLRERCPRGDDIL	CASP8	426	Q14790
RGFLTERDDILCPDC	FHL2	261	Q14192
EEPVSELLRRCGNCT	MANBA	751	O00462
ICDGERDENHPNLIR	GLTP	111	Q9NZD2
LASCLDVDECRERGP	LTBP4	956	Q8N2S1
EDCRILLSVEPTDQG	FBLIM1	336	Q8WUP2
PRDCLDVLLSGQQDD	FIBCD1	241	Q8N539
RRLAGVCPEGLQDSD	INSC	541	Q1MX18
QTPDCRLSDSREGEE	KLF11	191	O14901
ALEALGCECRIEPQR	EME2	96	A4GXA9
QECCSPELGRRLAEL	EMILIN1	351	Q9Y6C2
DPVIRECRLRNSEGE	ERCC3	191	P19447
GRLLEALCREEPVVQ	FANCE	61	Q9HB96
LNLVARNECSRDGDP	ATRIP	386	Q8WXE1
LDIDECRTIPEACRG	FBLN5	41	Q9UBX5
CNLDDALSVRDLGPR	HELZ2	1351	Q9BYK8
AGRELPARLDSVDAC	HELZ2	1471	Q9BYK8
IEADSPAERCGVLQI	GRIP1	506	Q9Y3R0
TRFQGDVDEDLICPI	RNF41	6	Q9H4P4
RVEAPLVCREGESIQ	SEC14L5	586	O43304
LGLCDQVDDPDLRRC	IPO4	571	Q8TEX9
GPEIRRAISCDLQDD	CACNA1D	1651	Q01668
RIEDDLVFGICSPRE	COL6A6	786	A6NMZ7
IDVDADRPDCVEGRI	PIDD1	676	Q9HB75
LDCREQEQLERELAP	HGH1	366	Q9BTY7
FSCQLEPGERLREVC	PHKG1	171	Q16816
PCEAVSIDLDRNGLR	NYX	61	Q9GZU5
GSLRLDCPAAVVDDN	NRIP3	176	Q9NQ35
VCRDIDTLRDPGSQL	IGF2R	211	P11717
LEREPVRGQCLDSTD	RTN2	246	O75298
PRDLCCLLQVDGEAR	SYDE1	286	Q6ZW31
EGPCLTREVAQLRAE	TARS3	46	A2RTX5
PSSCRRKQEDDRDGL	TMEM106C	11	Q9BVX2
DRTDPLQGRDLVREC	RAPGEF6	241	Q8TEU7
LLRDIQESCGDPEAV	PLEKHH3	211	Q7Z736
ERRCDLRPDCQDGSD	SSPOP	2481	A2VEC9
ADACPLAELRAAGLE	RPS6KB2	26	Q9UBS0
CRLLGPEEDEEELAA	NHSL2	81	Q5HYW2
DQDPSCPRLSRELLD	NBPF8	651	Q3BBV2
DQDPSCPRLSRELLD	NBPF9	686	P0DPF3
DQDPSCPRLSRELLD	NBPF10	686	Q6P3W6
EEDQDPSCPRLSREL	NBPF10	1416	Q6P3W6
DQDPSCPRLSRELLD	NBPF10	1906	Q6P3W6
EEDQDPSCPRLSREL	NBPF10	2636	Q6P3W6
DQDPSCPRLSRELLD	NBPF10	3126	Q6P3W6
DQDPSCPRLSRELLD	NBPF14	346	Q5TI25
EEDQDPSCPRLSREL	NBPF19	901	A0A087WUL8
DQDPSCPRLSRELLD	NBPF19	1391	A0A087WUL8
EEDQDPSCPRLSREL	NBPF19	2121	A0A087WUL8
DQDPSCPRLSRELLD	NBPF19	2611	A0A087WUL8
EEDQDPSCPRLSREL	NBPF19	3341	A0A087WUL8
DQDPSCPRLSRELLD	NBPF20	71	P0DPF2
EEDQDPSCPRLSREL	NBPF20	801	P0DPF2
DQDPSCPRLSRELLD	NBPF20	1291	P0DPF2
EEDQDPSCPRLSREL	NBPF20	2021	P0DPF2
DQDPSCPRLSRELLD	NBPF20	2511	P0DPF2
EEDQDPSCPRLSREL	NBPF20	3241	P0DPF2
DQDPSCPRLSRELLD	NBPF20	3731	P0DPF2
DQDPSCPRLSRELLD	NBPF20	4951	P0DPF2
DQDPSCPRLSRELLD	NBPF26	646	B4DH59
VCRNGLLVIRDDPEG	NXN	146	Q6DKJ4
GPCLEQQDEERSTRL	RECQL4	1086	O94761
ECREGTFALRADNPL	LAMA1	1131	P25391
AVCRPAGIQDEDITL	SMG1	1676	Q96Q15
AQLLEECPRDETSGL	EPPK1	1096	P58107
RGDALERFCLQQPLD	MFAP4	26	P55083
DEAEPVGALLLERCR	PLEKHJ1	51	Q9NW61
EAQAPGREEDRSCDA	PPARGC1B	731	Q86YN6
ELQDVECEERPRGSS	PTCH1	1431	Q13635
RCESGFIEELPEETR	RNF126	31	Q9BV68
EEERRCLLQGTGVPE	SETD6	161	Q8TBK2
ICLAQLGEPELRDSR	TELO2	366	Q9Y4R8
VVDCCTDPDGRAVDR	PLA2G6	731	O60733
QLRRELRQAAECGPE	RDH14	86	Q9HBH5
SEVLGECARRSQPER	RNF169	126	Q8NCN4
QACRTPSRDEAGVEL	RHPN2	156	Q8IUC4
LDVCPVSARQLEGVD	SETD1A	1511	O15047
SEQAELPRCRQVGDH	OAF	196	Q86UD1
CDLNGRPREAEVRFL	OS9	181	Q13438
DGEEQVRRLGPLACF	STRC	921	Q7RTU9
VRVGDLPCDSVEDQL	RIOX1	606	Q9H6W3
ESLEREVGRLCQRSP	SPTBN5	2421	Q9NRC6
RLRECELSPGVNRDL	SRRT	486	Q9BXP5
PVSQECFETLRGDER	CHGA	51	P10645
RCPLRGADRADVADV	CHPF	411	Q8IZ52
PRARAEVGLVEDTAC	CHST7	211	Q9NS84
EEDPLDQLISRSGCA	COA4	21	Q9NYJ1
GCQLAPERGAERRDT	COA8	36	Q96IL0
PTEFIREGDDDRTVC	CLU	271	P10909
EAETGLAEPRALCAQ	SLC49A3	6	Q6UXD7
DDREEDGCSQAVPLV	TIMELESS	1031	Q9UNS1
EFIRSLPGCQEIAEE	PHC2	801	Q8IXK0
GCSPDIRQIDLDVNR	USP6NL	136	Q92738
LDAGLCTCPREESRE	ZNF565	16	Q8N9K5
CGDLASEIREDAVAP	VSIG8	316	P0DPA2
RPEEIELLICGSRNL	UBE3A	751	Q05086
CILAEVEGRALPDSQ	RGS12	831	O14924
ARLQGLEADCVRGPD	PBXIP1	336	Q96AQ6
RQEAGRELLIPCAAA	IGSF9B	431	Q9UPX0
PSELERQEDQGCVRI	KIF20A	76	O95235
LIEDGERCVRPAGNA	SAP30L	31	Q9HAJ7
IRRAIEDISQGCPES	SPRED1	116	Q7Z699
VEEVSCLRPREARDG	SPOCD1	156	Q6ZMY3
VDDRECPVRRNGQGD	PFAS	601	O15067
LQAEPRCVAEEERGL	PFAS	1021	O15067
GALRELLEACRNGDV	TNKS	181	O95271
ALDCGRPDSLLSEER	VPS18	296	Q9P253
DVLRPLEQALEDCRG	SRA1	101	Q9HD15
EALRGICPGDEARTE	ZNF620	81	Q6ZNG0
PQLREQCGLELSIDR	USP47	1161	Q96K76
CNGRALEEPAEEEVL	ZNF710	71	Q8N1W2
RLAGRQAELCQAEPE	WNT6	46	Q9Y6F9
ACLPGEEGTAERIER	TMCC1	181	O94876
LAELQEADGQCPVDR	ACP6	31	Q9NPH0
RECLLAEAEGRPLRE	RGS14	181	O43566
RQLLERCVEDPETGL	PLEC	3661	Q15149
TGPEARCAALREEFL	IGSF9	1136	Q9P2J2
LLREAEGRQVPDSCC	TSPAN11	171	A1L157
CALDGALERPENEAS	ZNF469	3541	Q96JG9
DQPRDILCGAADEVL	SNRNP200	126	O75643
SEAEHPLLCEGTRRE	ZSWIM8	971	A7E2V4
PECRNDASEVVLAGE	UHRF1	361	Q96T88
PQSRDGVLLSREECL	TSPAN18	181	Q96SJ8
LREDIAQIPTCAEAG	ZKSCAN3	281	Q9BRR0
DGEEQVRRLGPLACF	STRCP1	921	A6NGW2
EERDCPTARTDIGDV	PIPOX	281	Q9P0Z9
DLDLLGDCRNPRLDL	TASOR2	1831	Q5VWN6
DRDQDCLLPVEEAGI	PIEZO1	1271	Q92508
EREVELLRDAGGCVN	TBX1	356	O43435
LVLRFGRDEDPVCLQ	TXNL4B	26	Q9NX01
RRPEVCERSCEELGN	THBS2	261	P35442
DNDGVPDDRDNCRLV	THBS2	901	P35442
PETEEGAAELRLRCL	VSIG10L	311	Q86VR7
VGEHIDRDCRSDPAQ	ZFAND2B	76	Q8WV99
QLCRREPGLAETLRD	WNT9B	66	O14905
ELCEQESECRGDPVR	SLIT1	1451	O75093
RVLTDGELAPNDRCC	TUT4	1281	Q5TAX3
ANVVRLLGLCREAEP	PTK7	856	Q13308
NGKISRLRRECPSDE	RPS27A	111	P62979
ANTRPDLDLRDPICD	PLD2	826	O14939
EELLEACRTEGSPLR	ZFYVE26	241	Q68DK2
DGCREDRVENETRPQ	ZMYND15	176	Q9H091
GLRAVESRCERQLPE	MST1R	806	Q04912
PCSRELQRDLAGEEA	ZNF185	316	O15231
LREEEAALGCPARTL	XRCC3	301	O43542
CPRAEGLGEAEVRTL	WDR81	76	Q562E7
LVTDQDAGLLPRCRE	TRIO	2171	O75962
EDEDLGQIFTIRRCP	ZFHX3	1131	Q15911
DLCSAQDPREQEELR	ZAN	2576	Q9Y493
ERGLVRQEEAEDPAC	PLK1	391	P53350
RLPEGEALQCLTERA	KDM5C	1271	P41229
TEELRRCGADIPSQE	MX2	401	P20592
IAEALSRPGREACLE	NACAD	1041	O15069
LRSEQDPTDEDPCRG	MZF1	311	P28698
RSPECLDLLVDSGAE	NFKB2	611	Q00653